ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Cempra
2.33
0.0000
成交量:
- -
成交額:
- -
市值:
- -
市盈率:
- -
高:
2.33
開:
2.33
低:
2.33
收:
2.33
52周最高:
9.40
52周最低:
2.05
股本:
- -
流通股本:
- -
量比:
- -
換手率:
- -
股息:
- -
股息率:
- -
淨資產收益率:
--
總資產收益率:
--
市淨率:
0.00
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字:
Cempra
交易所:
NASDAQ
成立時間:
- -
員工人數:
- -
公司地址:
- -
官網:
http://www.cempra.com
郵編:
- -
電話:
- -
傳真:
- -
簡介:
Cempra, Inc.是Cempra製藥公司的繼承實體。Cempra製藥公司於2005年11月18日成立,並於2006年1月開始運作。Cempra公司位於北卡羅來納州教堂山市,是一家在社區和醫院開發用以治療抗藥細菌感染藥物的製藥公司。Cempra公司是一家臨床階段製藥公司,致力於開發抗生素,以滿足在治療感染性疾病過程中的關鍵醫療需求,特別是呼吸道感染和慢性葡萄球菌感染。該公司的主導程序是solithromycin(CEM-101)。而該公司目前正在以口服和靜脈注射(IV)的形式開發該程序。該程序的開發最初是為治療社區獲得性細菌性肺炎(CABP),該炎症是最嚴重的呼吸道感染之一。該公司已經成功地完成了治療CABP的口服製劑2期臨床試驗,显示了良好的安全性和耐受性,以及可以與目前的護理標準,左氧氟沙星(一種呼吸性氟喹諾酮類藥物)相媲美可比較的護理療效。
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/CEMP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CEMP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEMP\",,,,,undefined,":{"symbol":"CEMP","market":"US","secType":"STK","nameCN":"Cempra","latestPrice":2.325,"timestamp":1515186000000,"preClose":2.325,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"休市中","change":0,"latestTime":"01-05 16:00:00 EST","open":2.325,"high":2.325,"low":2.325,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773648000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":2.325,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEMP\",,,,,undefined,":{"symbol":"CEMP","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"shares":0,"dividePrice":0,"high":2.325,"amplitude":0,"preClose":2.325,"low":2.325,"week52Low":2.05,"pbRate":"0.00","week52High":9.4,"institutionHeld":0,"latestPrice":2.325,"eps":0,"divideRate":0,"volume":0,"delay":0,"open":2.325,"prevYearClose":2.325},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEMP\",params:#limit:5,,,undefined,":[{"date":"2017-11-06","symbol":"CEMP","newSymbol":"MLNT","type":"symbolChange","dateTimestamp":1509944400000},{"date":"2017-11-06","symbol":"CEMP","type":"split","dateTimestamp":1509944400000,"forFactor":5,"toFactor":1},{"market":"US","date":"2017-08-09","symbol":"CEMP","fiscalQuarterEnding":"2017/06","expectedEps":-0.32,"name":null,"time":"盤前","type":"earning","dateTimestamp":1502251200000,"reportTimeType":"pre","actualEps":-0.23},{"market":"US","date":"2017-04-28","symbol":"CEMP","fiscalQuarterEnding":"2017/03","expectedEps":-0.53,"name":null,"time":"盤前","type":"earning","dateTimestamp":1493352000000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2017-02-28","symbol":"CEMP","fiscalQuarterEnding":"2016/12","expectedEps":-0.57,"name":null,"time":"盤前","type":"earning","dateTimestamp":1488258000000,"reportTimeType":"pre","actualEps":-0.6}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEMP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEMP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.cempra.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.015},{"period":"1month","weight":-0.0429},{"period":"3month","weight":-0.0286},{"period":"6month","weight":0.0074},{"period":"1year","weight":0.2011},{"period":"ytd","weight":-0.0288}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Cempra, Inc.是Cempra製藥公司的繼承實體。Cempra製藥公司於2005年11月18日成立,並於2006年1月開始運作。Cempra公司位於北卡羅來納州教堂山市,是一家在社區和醫院開發用以治療抗藥細菌感染藥物的製藥公司。Cempra公司是一家臨床階段製藥公司,致力於開發抗生素,以滿足在治療感染性疾病過程中的關鍵醫療需求,特別是呼吸道感染和慢性葡萄球菌感染。該公司的主導程序是solithromycin(CEM-101)。而該公司目前正在以口服和靜脈注射(IV)的形式開發該程序。該程序的開發最初是為治療社區獲得性細菌性肺炎(CABP),該炎症是最嚴重的呼吸道感染之一。該公司已經成功地完成了治療CABP的口服製劑2期臨床試驗,显示了良好的安全性和耐受性,以及可以與目前的護理標準,左氧氟沙星(一種呼吸性氟喹諾酮類藥物)相媲美可比較的護理療效。","exchange":"NASDAQ","name":"Cempra","nameEN":"Cempra"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CEMP\",market:\"US\",,,undefined,":null}}